Start Your Risk-Free Trial

DIRA (Deficiency of IL-1RA) Medication Savings with TheDrugClub

Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.

  1. Join TheDrugClub as a member
  2. Receive your member card by email
  3. Present your card at a participating pharmacy
  4. Check active-formulary eligibility or available discount pricing

About DIRA (Deficiency of IL-1RA)

Understanding DIRA Deficiency: A Rare Inflammatory Challenge

Deficiency of the Interleukin-1 Receptor Antagonist, or DIRA, is a very rare and severe genetic inflammatory disease. Present from birth, DIRA is characterized by a systemic inflammatory response that can affect multiple organs. At its core, DIRA is caused by a genetic mutation that prevents the body from producing enough, or any, of a crucial protein called interleukin-1 receptor antagonist (IL-1ra).

Normally, IL-1ra acts as a natural brake on inflammation by blocking the activity of interleukin-1 (IL-1), a powerful pro-inflammatory cytokine. Without sufficient IL-1ra, IL-1 runs unchecked, leading to widespread and persistent inflammation. Infants with DIRA typically experience symptoms such as recurrent fevers, skin rashes (pustulosis), and painful bone lesions (osteomyelitis). If left untreated, the chronic inflammation can lead to significant morbidity and even be life-threatening.

Diagnosis of DIRA often involves genetic testing to identify the specific mutations, along with blood tests showing elevated inflammatory markers. Early diagnosis and treatment are critical to prevent irreversible organ damage and improve quality of life.

Treatment for DIRA: The Role of Anakinra

The primary and most effective treatment for DIRA deficiency is a medication called anakinra, marketed under the brand name Kineret. Anakinra is a recombinant human IL-1ra, meaning it's a manufactured version of the protein the body is missing. By administering daily injections of anakinra

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

Related conditions

Participating pharmacy savings paths

Start Your Risk-Free Trial
Start Your Risk-Free Trial